Leo Cui, PhD

Leo is a biotech expert with extensive research experience in CRISPR and Microfluidics. He was a Postdoc fellow in Professor Feng Zhang's Lab at MIT Broad Institute. He is a core inventor of 4 patents and has authored 8 peer-reviewed scientific publications. His work has led to two spin-off companies which are developing early-stage cancer diagnostics and a high-throughput drug discovery platform. Leo is passionate about the converging power of bioscience and bioengineering. He co-founded Nucleate, a student-run entrepreneurship club at Harvard, and grew the program to 6 other Biohubs in the US. Leo holds a Ph.D. in Bioengineering from Harvard University. He is based in our office in Cambridge, MA. ​ Select Investments: Omniscope, Zafrens, Colabra, Palamedrix.